MetLife Investment Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $454K | Hold |
|
|||||
|
2025
Q2 | $312K | Hold |
|
|||||
|
2025
Q1 | $252K | Hold |
|
|||||
|
2024
Q4 | $242K | Buy |
|
|||||
|
2024
Q3 | $254K | Hold |
|
|||||
|
2024
Q2 | $336K | Buy |
|
|||||
|
2024
Q1 | $219K | Hold |
|
|||||
|
2023
Q4 | $219K | Buy |
|
|||||
|
2023
Q3 | $146K | Hold |
|
|||||
|
2023
Q2 | $108K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $124K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $169K | Sell |
|
|||||
|
2020
Q4 | $180K | Hold |
|
|||||
|
2020
Q3 | $193K | Hold |
|
|||||
|
2020
Q2 | $261K | Hold |
|
|||||
|
2020
Q1 | $178K | Hold |
|
|||||
|
2019
Q4 | $333K | Hold |
|
|||||
|
2019
Q3 | $238K | Buy |
|